SE9403915D0 - Process A - Google Patents
Process AInfo
- Publication number
- SE9403915D0 SE9403915D0 SE9403915A SE9403915A SE9403915D0 SE 9403915 D0 SE9403915 D0 SE 9403915D0 SE 9403915 A SE9403915 A SE 9403915A SE 9403915 A SE9403915 A SE 9403915A SE 9403915 D0 SE9403915 D0 SE 9403915D0
- Authority
- SE
- Sweden
- Prior art keywords
- factor viii
- pct
- date
- recombinant
- protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403915A SE9403915D0 (sv) | 1994-11-14 | 1994-11-14 | Process A |
JP51599396A JP3787154B2 (ja) | 1994-11-14 | 1995-11-14 | Viii因子の精製方法 |
PCT/SE1995/001351 WO1996015150A1 (en) | 1994-11-14 | 1995-11-14 | Process for purifying factor viii |
CA2202875A CA2202875C (en) | 1994-11-14 | 1995-11-14 | Process for purifying factor viii |
US08/809,756 US5831026A (en) | 1994-11-14 | 1995-11-14 | Process for purifying factor VIII |
DE69534383T DE69534383T2 (de) | 1994-11-14 | 1995-11-14 | Verfahren zur aufreinigung des faktors viii |
NZ295811A NZ295811A (en) | 1994-11-14 | 1995-11-14 | Protease resistant factor viii composition containing inhibitors of zinc dependent proteases added to a solution after harvest |
EP95937286A EP0784633B1 (en) | 1994-11-14 | 1995-11-14 | Process for purifying factor viii |
AU39439/95A AU691692B2 (en) | 1994-11-14 | 1995-11-14 | Process for purifying factor VIII |
AT95937286T ATE302216T1 (de) | 1994-11-14 | 1995-11-14 | Verfahren zur aufreinigung des faktors viii |
MX9703552A MX9703552A (es) | 1994-11-14 | 1995-11-14 | Proceso de purificacion de factor viii. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9403915A SE9403915D0 (sv) | 1994-11-14 | 1994-11-14 | Process A |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9403915D0 true SE9403915D0 (sv) | 1994-11-14 |
Family
ID=20395964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9403915A SE9403915D0 (sv) | 1994-11-14 | 1994-11-14 | Process A |
Country Status (11)
Country | Link |
---|---|
US (1) | US5831026A (es) |
EP (1) | EP0784633B1 (es) |
JP (1) | JP3787154B2 (es) |
AT (1) | ATE302216T1 (es) |
AU (1) | AU691692B2 (es) |
CA (1) | CA2202875C (es) |
DE (1) | DE69534383T2 (es) |
MX (1) | MX9703552A (es) |
NZ (1) | NZ295811A (es) |
SE (1) | SE9403915D0 (es) |
WO (1) | WO1996015150A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605222B1 (en) * | 1998-05-20 | 2003-08-12 | Baxter Aktiengesellschaft | Method for producing a factor VIII/von Willebrand factor complex |
EP1820516B1 (en) | 1999-02-22 | 2013-07-24 | University of Connecticut | Novel albumin-free factor VIII formulations |
AU3194900A (en) * | 1999-03-19 | 2000-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Method for screening cysteine protease inhibitor |
US6338964B1 (en) * | 1999-05-07 | 2002-01-15 | Bayer Corporation | Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration |
IL162239A0 (en) | 2001-12-21 | 2005-11-20 | Novo Nordisk Healthcare Ag | Liquid composition of factor vii polypeptides |
KR20040065278A (ko) * | 2001-12-21 | 2004-07-21 | 노보 노르디스크 에이/에스 | 변경된 인자 ⅶ 폴리펩티드의 액체 조성물 |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
WO2004000347A1 (en) | 2002-06-21 | 2003-12-31 | Novo Nordisk A/S | Stabilised solid compositions of factor vii polypeptides |
BRPI0408439A (pt) * | 2003-03-18 | 2006-04-04 | Novo Nordisk Healthcare Ag | composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
JP5627832B2 (ja) * | 2003-05-23 | 2014-11-19 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 溶液中におけるタンパク質の安定化 |
JP4658041B2 (ja) * | 2003-06-25 | 2011-03-23 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | Vii因子ポリペプチドの液体組成物 |
EP1644030B1 (en) * | 2003-07-01 | 2009-10-28 | Novo Nordisk Health Care AG | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
JP5653572B2 (ja) * | 2003-08-14 | 2015-01-14 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 第vii因子ポリペプチドの液状水性医薬組成物 |
ES2229931B1 (es) * | 2003-10-03 | 2006-01-16 | Grifols, S.A. | Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos. |
WO2005058283A2 (en) * | 2003-12-19 | 2005-06-30 | Novo Nordisk Health Care Ag | Stabilised compositions of factor vii polypeptides |
EP1707634A1 (en) | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
WO2008135498A2 (en) * | 2007-05-04 | 2008-11-13 | Novo Nordisk A/S | Prevention of protein degradation in mammalian cell cultures |
EP2113564A1 (en) * | 2008-05-01 | 2009-11-04 | Arecor Limited | Protein formulation |
KR20160104740A (ko) * | 2008-06-24 | 2016-09-05 | 옥타파마 아게 | 응고 인자 viii을 정제하는 방법 |
RU2011110459A (ru) | 2008-08-21 | 2012-09-27 | Октафарма АГ (CH) | Рекомбинантно полученный человеческий фактор viii и ix |
PT2337580E (pt) * | 2008-09-03 | 2012-05-28 | Octapharma Ag | Composições estabilizadas para o factor viii produzido de forma recombinante |
CA2742328C (en) | 2008-11-07 | 2019-02-26 | Baxter International Inc. | Factor viii formulations |
GB0915480D0 (en) | 2009-09-04 | 2009-10-07 | Arecor Ltd | Stable formulation of factor viii |
BRPI1105317A2 (pt) | 2011-01-24 | 2013-04-30 | Fundacco Hemoct De Ribeirco Preto | produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4289691A (en) * | 1980-01-18 | 1981-09-15 | The Canadian Red Cross Society | Method of obtaining intermediate purity factor VIII |
US4406886A (en) * | 1983-01-14 | 1983-09-27 | University Patents, Inc. | Purification of antihemophilia factor VIII by precipitation with zinc ions |
IL74909A (en) * | 1984-04-20 | 1992-01-15 | Genentech Inc | Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein |
US5149787A (en) * | 1984-05-22 | 1992-09-22 | The Blood Center Research Foundation | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
US4710381A (en) * | 1984-05-22 | 1987-12-01 | The Blood Center Of Southeastern Wisconsin | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
CA1329760C (en) * | 1987-10-29 | 1994-05-24 | Ted C. K. Lee | Plasma and recombinant protein formulations in high ionic strength media |
US4877608A (en) * | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
US4981951A (en) * | 1988-04-14 | 1991-01-01 | Miles Inc. | Lectin affinity chromatography of factor VIII |
WO1990002175A1 (en) * | 1988-08-16 | 1990-03-08 | Novo Nordisk A/S | A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
US5110907A (en) * | 1989-08-01 | 1992-05-05 | Alpha Therapeutic Corporation | Factor viii complex purification using heparin affinity chromatography |
DE3926034C3 (de) * | 1989-08-07 | 1996-11-21 | Behringwerke Ag | Verfahren zur Herstellung eines stabilen Faktors VIII |
SE465222C5 (sv) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
IT1248723B (it) * | 1990-06-12 | 1995-01-26 | Scalvo S P A | Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo |
WO1992013944A1 (en) * | 1991-02-04 | 1992-08-20 | Berlex Laboratories, Inc. | Endothelin converting enzyme |
SE468050C (sv) * | 1991-03-15 | 1998-02-11 | Pharmacia & Upjohn Ab | Rekombinant derivat av human faktor VIII |
CA2078721A1 (en) * | 1991-09-24 | 1993-03-25 | Hiroshi Yonemura | Process for preparing human coagulation factor viii protein complex |
US5278289A (en) * | 1991-11-12 | 1994-01-11 | Johnson Alan J | Antihemophilic factor stabilization |
AU670793B2 (en) * | 1992-04-30 | 1996-08-01 | Alpha Therapeutic Corporation | Improved solubilization and stabilization of factor VIII complex |
US5288853A (en) * | 1992-04-30 | 1994-02-22 | Alpha Therapeutic Corporation | Factor viii purification process |
GB9211538D0 (en) * | 1992-06-01 | 1992-07-15 | Blake David R | Antiinflammatory agent |
NZ256921A (en) * | 1992-10-02 | 1996-05-28 | Pharmacia Ab | Formulations of coagulation factor viii and a non-ionic surfactant and their preparation |
SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
SE504074C2 (sv) * | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
IL113010A0 (en) * | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
-
1994
- 1994-11-14 SE SE9403915A patent/SE9403915D0/xx unknown
-
1995
- 1995-11-14 MX MX9703552A patent/MX9703552A/es unknown
- 1995-11-14 WO PCT/SE1995/001351 patent/WO1996015150A1/en active IP Right Grant
- 1995-11-14 US US08/809,756 patent/US5831026A/en not_active Expired - Lifetime
- 1995-11-14 EP EP95937286A patent/EP0784633B1/en not_active Expired - Lifetime
- 1995-11-14 JP JP51599396A patent/JP3787154B2/ja not_active Expired - Lifetime
- 1995-11-14 NZ NZ295811A patent/NZ295811A/en not_active IP Right Cessation
- 1995-11-14 AT AT95937286T patent/ATE302216T1/de active
- 1995-11-14 AU AU39439/95A patent/AU691692B2/en not_active Expired
- 1995-11-14 CA CA2202875A patent/CA2202875C/en not_active Expired - Lifetime
- 1995-11-14 DE DE69534383T patent/DE69534383T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69534383T2 (de) | 2006-05-24 |
ATE302216T1 (de) | 2005-09-15 |
NZ295811A (en) | 1998-08-26 |
CA2202875C (en) | 2011-03-15 |
AU691692B2 (en) | 1998-05-21 |
JP3787154B2 (ja) | 2006-06-21 |
MX9703552A (es) | 1997-08-30 |
US5831026A (en) | 1998-11-03 |
JPH10509144A (ja) | 1998-09-08 |
DE69534383D1 (de) | 2005-09-22 |
EP0784633A1 (en) | 1997-07-23 |
CA2202875A1 (en) | 1996-05-23 |
AU3943995A (en) | 1996-06-06 |
WO1996015150A1 (en) | 1996-05-23 |
EP0784633B1 (en) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9403915D0 (sv) | Process A | |
DE69207920D1 (de) | Stabilisierte persäurelösungen | |
ATE83927T1 (de) | Thrombinzusammensetzung. | |
ES2072452T3 (es) | Medios cosmeticos desodorizantes. | |
BR9712792A (pt) | Inibidores de metaloprotease bidentada. | |
DE69513837T2 (de) | Cyklopeptolide | |
Ruenwongsa et al. | Acidic protease from human seminal plasma. Purification and some properties of active enzyme and of proenzyme. | |
DE59002760D1 (de) | K2p pro-stabilisierung. | |
NO2006006I1 (no) | Aktivert protein C | |
IT1169774B (it) | Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina | |
DE69227805T2 (de) | Verwendung von Tri-n-Butylphosphat bei niedrigem pH in Lösungen von biologisch aktiven Proteinen für eine verbesserte viruzide Wirkung | |
FI853962L (fi) | Buffrade glutaraldehyd innehaollande steriliserande och desinficerande kompositioner. | |
PT806206E (pt) | Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes | |
Nicolls et al. | Kidney urokinase activity following acute exposure to lead | |
Ikeno et al. | Effects of prolonged parotid duct ligation, parotidectomy and acute hepatitis of rats on amylase activity | |
ATE356220T1 (de) | Verfahren zur enzymatischen herstellung von fructosylverbindungen | |
SU1205553A1 (ru) | Способ получения глутамин(аспарагин)азы из pseudomonas aurantiaca вкмв-548 |